通过外周血液中的GSK3水平对单极与双极抑郁症的差异诊断:试点实验性研究

相关实验视频

Updated: Jul 14, 2025

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Published on: December 4, 2014

9.8K

Gianluca Rosso^1,2, Giuseppe Maina^3,4, Elena Teobaldi³

¹Department of Neurosciences ''Rita Levi Montalcini'', University of Turin, Via Cherasco 15, 10126, Turin, Italy. gianluca.rosso@unito.it.

International journal of bipolar disorders

|October 8, 2023

概括

周围血液细胞中的糖原合成激酶-3β (GSK3β) 可能有助于区分双极性疾病和单极性抑郁症. 这种潜在的生物标志物为抑郁症发作中准确诊断提供了一个新的途径.

科学领域:

神经科学是一个神经科学.
生物化学生物化学
精神病学是一个精神病学.

背景情况:

单极抑郁和双极抑郁之间的准确诊断对于有效治疗至关重要,但缺乏可靠的生物标志物.
建议糖原合成激酶-3 (GSK3) 参与抑郁症病理生理学,但外周血液标志物仍然不一致.
以前对外围血液中的GSK3用于抑郁症诊断的研究得出了不确定的结果.

研究的目的:

在周围血液细胞中研究糖原合成酶激酶-3α (GSK3α) 和GSK3β水平的一致差异.
确定潜在的外围生物标志物,以区分单极性抑郁症和双极性障碍.
评估GSK3α和GSK3β作为患有抑郁症的患者的诊断标记.

主要方法:

对患有抑郁情节的患者单核周围血液细胞 (PBMC) 的分析.
使用西部斑点技术量化GSK3α和GSK3β水平.
在被诊断患有单极抑郁症和双极障碍的患者之间比较蛋白质水平.

主要成果:

与单极抑郁症相比,双相情感障碍患者观察到总GSK3β水平显著降低.
作为潜在的诊断标记物,GSK3β显示出85%的灵敏度.
GSK3α没有显著差异,双相情感障碍患者的检测率为57%.
将GSK3β和GSK3α相结合,在系列中实现了接近100%的灵敏度,但包括26.7%的假阴性.

结论:

周围血液细胞GSK3β是区分双极性疾病和单极性抑郁症的有希望的候选生物标志物.
这一发现可以增强边缘生物标志物的有限小组,用于抑郁症发作中的差异诊断.
进一步验证PBMC GSK3β可能会提高临床环境中的诊断准确性.

关键词:

生物标志物生物标志物双极性障碍双极性障碍双极性障碍抑郁症抑郁症抑郁症差异诊断是一种差异诊断.这是GSK3的GSK3.大型抑郁症主要是抑郁症.

相关概念视频

01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.

01:18

Depression: Overview

263

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

263

01:27

Depressive Disorders: MDD and Dysthymia

143

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

143